Myofibroma

This is a small, non-cancerous (benign) lump or growth that forms in your muscles. It's made up of fibrous tissue, similar to scar tissue. Myofibromas are usually harmless and don't cause problems unless they grow very large or are in a sensitive area.

Condition

What people with Myofibroma report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Myofibroma

What It Is

A myofibroma is a rare, noncancerous tumor made of cells with features of both fibrous connective tissue cells and smooth muscle cells. It usually appears as a firm, painless lump in or just under the skin, sometimes with a reddish or purple tint, and it can also form in muscle or bone. Myofibromas do not spread to other parts of the body, but a growing one can press on nearby nerves, bone or organs. Most myofibromas are found in babies and young children, and many are present at birth. When several develop, the condition is called myofibromatosis (often infantile myofibromatosis). The forms differ a great deal. A single lump, the most common form, generally has a good outlook. Multiple lumps in the skin, muscle or bone often shrink over time. The rare form that also involves internal organs such as the lungs, heart or intestines is the most serious and can be life-threatening. Adults can develop a single myofibroma too, most often in the head and neck.

Causes & Risk Factors

In most people, a myofibroma appears without a family history, and its cause is unknown. A small number of families have an inherited form. Changes in the PDGFRB gene, which controls a growth signal on connective tissue cells, cause most of these cases and are passed on in an autosomal dominant pattern: a parent with the variant has a 50% chance of passing it to each child. Family members who share the variant may be affected differently, and some have no tumors at all. A few families have a change in a different gene, NOTCH3; how it is passed on is less well understood, which is one reason genetic counseling helps. In some people, a PDGFRB change is found in the tumors or in some tissues but not throughout the body, meaning it arose after conception rather than being inherited.

How It's Diagnosed

A clinician examines the lump and asks when it appeared and whether it has changed. Ultrasound or magnetic resonance imaging (MRI) shows the size and depth of the growth, whether it involves muscle or bone, and, in a child with several lumps, whether internal organs are affected. Imaging is also used later to track whether lesions are shrinking, growing or coming back. Imaging alone cannot confirm a myofibroma, because it can look like many other growths, from a harmless fatty lump to a cancer such as a sarcoma. The diagnosis is made by taking a tissue sample (a biopsy) or removing the lump and examining it under a microscope. When several family members are affected or a child has many tumors, a genetic test, usually on a blood sample, can look for a PDGFRB or NOTCH3 change. A genetic result helps with family testing and planning, and it can point toward a targeted treatment.

Treatment Options

There are no standard treatment guidelines, because the condition is rare and the experience comes mostly from case reports and small series. Treatment depends on how many tumors there are, where they are and whether they cause problems. For lumps that are not causing symptoms and do not involve internal organs, careful observation is often the first approach, since many shrink or disappear on their own. Surgery to remove the tumor is the main treatment when a lump is causing symptoms, keeps growing, sits close to a vital structure or involves an organ. A single myofibroma in a child or adult is often simply removed, which usually ends the problem. When tumors involve internal organs and surgery is not possible or has not worked, children have been treated with chemotherapy, most often a combination of methotrexate and vinblastine, given under a pediatric cancer team even though the tumor is benign. For people whose disease is driven by a PDGFRB change, imatinib, a targeted medicine that blocks the overactive growth signal, has helped in several severe cases. These medicines have their own side effects and monitoring, which is one reason they are reserved for serious disease.

What to Expect

For most people, a myofibroma is a one-time problem. A single lump that is removed or left to shrink usually causes no further trouble, although about 1 in 10 return after surgery, and an occasional lump can leave a scar or affect the shape of the area it grew in. Myofibromatosis, with multiple lumps, is less predictable. Lumps often fade over months to a few years, but new ones can appear, and some people develop recurrences later in childhood or even as adults. Follow-up visits, with imaging when needed, help catch growth that could affect bones, nerves or movement. When internal organs are involved, care is more intensive and the outlook depends on which organs are affected and how they respond to treatment. Families of a child with an inherited form may also want genetic counseling to understand what it means for siblings and future pregnancies.

When to Seek Help

Arrange a medical evaluation for any new firm lump in a baby, child or adult that grows, changes color, breaks down or does not go away, so it can be identified properly. For someone already diagnosed, contact the care team promptly if a known lump grows quickly, a new lump appears, or a lump starts causing pain, numbness, weakness or limited movement. In an infant with multiple myofibromas, contact the care team right away about breathing changes, feeding problems, repeated vomiting or poor weight gain, since these can be signs that internal organs are involved. If the baby is struggling to breathe, or the lips or skin turn blue or gray, call 911.

Questions to Ask Your Doctor

  1. 1.Is this a single myofibroma or myofibromatosis, and have we checked whether any internal organs are involved?
  2. 2.Is it reasonable to watch this lump, or should it be removed, and what would change that decision?
  3. 3.How often should follow-up visits and imaging happen, and for how many years?
  4. 4.Should we consider genetic testing, and what would a result mean for treatment or for other family members?

Last reviewed • Oct 2026

Educational content, not medical advice.